Latest Shareholder Approvals News

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

Jindalee Lithium has signed a non-binding LOI to merge its US lithium assets with a US SPAC, aiming to list on a national exchange and unlock significant funding for its McDermitt Project.

Lindian Resources has won shareholder approval for a A$91.5 million institutional placement, fully financing its Kangankunde Rare Earths Project through to first production targeted in late 2026.

Elixinol Wellness has raised $2.5 million through a well-supported placement and appointed industry veteran Gavin Evans as strategic advisor to drive its next phase of growth and operational reset.

Wagners Holding Company Limited has secured $30 million through a strongly supported placement to fund growth in its construction materials and composite fibre technologies divisions.

Kuniko Limited updates its prospectus to extend its entitlement offer, enter a joint venture for the Commonwealth Project, and secure partial underwriting from GBA Capital.

Asra Minerals has raised $3.25 million to fast-track exploration at its Leonora Gold Projects in Western Australia, targeting high-grade zones and new prospects.

MIXI Australia confirms its final $1.25 per share offer for PointsBet, now holding a majority stake and closing the bid on 12 September 2025. Shareholders face a decisive moment as the offer will not be extended or increased.

The Takeovers Panel has approved a key variation to betr Entertainment’s undertaking, removing shareholder approval hurdles for MIXI Australia’s participation in a selective share buy-back tied to its competing bid for PointsBet.

M3 Mining Limited has raised $2.25 million through a share placement to fund exploration at its Victorian projects and pursue strategic acquisitions, signaling a renewed focus under new leadership.

Imagion Biosystems has reached key milestones in its MagSense® HER2 breast cancer imaging program, including starting manufacturing for its Phase 2 trial and launching an AI imaging protocol collaboration with Wayne State University.

Metal Powder Works Limited has completed a A$15 million institutional placement, strengthening its balance sheet to scale production and expand its market presence.